🔎 Trials Near Me

Hjem › Lungesygdomme › Massachusetts

Lungesygdomme kliniske forsøg i Massachusetts

15 studier for Lungesygdomme søger deltagere på steder i Massachusetts.

Byer i Massachusetts

Officiel studietekst (engelsk)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Dana-Farber Cancer Institute, Boston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06765109

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Brigham and Women's Hospital, Boston
  • Lucida Clinical Trials, New Bedford
  • University of Massachusetts Chan Medical School, Worcester
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Brigham and Women's Hospital, Boston
  • Clinical Trials Center, Boston
  • Clinical Trials Hub, Boston
  • og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Brigham and Women's Hospital, Boston
RekruttererFase 2
Alder 40 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07759245

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Dana Farber Cancer Institute, Boston
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Boston Medical Center, Boston
  • Lahey Hospital & Medical Center, Burlington
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Infinity Medical Research, North Dartmouth
RekruttererFase 3
Alder 40 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07284602

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Boston
RekruttererFase 2
Alder 18 til 85 · Alle køn · Opdateret 2. sep. 2026 · NCT07333183

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  • Beth Israel Deaconess Medical Center, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT05967689

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 10. jun. 2026 · NCT05922761

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Massachusetts General Hospital,, Boston
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 19. feb. 2026 · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Dana-Farber Cancer Institute, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06619561

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

  • Brigham and Women's Hospital, Boston
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2025 · NCT04555161

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.